🇺🇸 AMGN — Amgen Inc.

Salud Mantener
← Volver

Precio actual

461,26 USD

Máx. histórico

466,01

4 días

Split 2:1 del 22/11/1999

Caída desde máximo

-1,02%

Rango 52 semanas

294,48 – 475,65

Variación hoy

-0,90%

Cierre anterior

465,45

Rango de hoy

460,15 – 467,02

Volumen hoy

2.351.852

Peor caída histórica

-78,03%

17/06/1983 → 19/11/1984

Recuperado en 487 días

Volatilidad anualizada ⓘ

37,45%

Información
Nombre completo
Amgen Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
31.500
PER ⓘ
28,65 (puede no estar actualizado)
Dividend yield
2,17% (puede no estar actualizado)
Precio objetivo analistas
397,32 USD (puede no estar actualizado)
Primera cotización
17/06/1983
Precio actualizado
hace 18 horas
Sobre la empresa

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including PROLIA, REPATHA, OTEZLA, ENBREL, EVENITY, XGEVA, TEPEZZA, BLINCYTO, NPLATE, TEZSPIRE, KYPROLIS, ARANESP, KRYSTEXXA AND VECTIBIX, MVASI, PAVBLU, UPLIZNA, IMDELLTRA/IMDYLLTRA, AMJEVITA/AMGEVITA, TAVNEOS, NEULASTA, LUMAKRAS/LUMYKRAS, RAVICTI, PARSABIV, AIMOVIG, WEZLANA/WEZENLA, AND PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; BEONE MEDICINES LTD. to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. The company was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Dividendos repartidos Total últimos 12 meses: 9,9400 USD · Yield: 2,15%
Fecha de pago Importe por participación
21/08/2026 2,5200 USD
15/05/2026 2,5200 USD
13/02/2026 2,5200 USD
21/11/2025 2,3800 USD
22/08/2025 2,3800 USD
16/05/2025 2,3800 USD
14/02/2025 2,3800 USD
18/11/2024 2,2500 USD
16/08/2024 2,2500 USD
16/05/2024 2,2500 USD
15/02/2024 2,2500 USD
16/11/2023 2,1300 USD
17/08/2023 2,1300 USD
17/05/2023 2,1300 USD
14/02/2023 2,1300 USD
Splits Registrados en el histórico de precios
Fecha Ratio
22/11/1999 2:1
01/03/1999 2:1
16/08/1995 2:1
11/09/1991 3:1
13/08/1990 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
10/10/2022 231,08 234,14 229,89 232,15 +1,36% 1,84% 1.630.100
07/10/2022 230,00 231,52 228,57 229,03 -0,83% 1,28% 2.060.000
06/10/2022 232,52 233,14 230,23 230,94 -1,23% 1,25% 1.523.800
05/10/2022 232,63 235,42 230,96 233,82 +0,34% 1,92% 2.060.400
04/10/2022 230,98 234,09 229,80 233,02 +1,12% 1,86% 2.331.000
03/10/2022 228,27 230,95 226,42 230,44 +2,24% 1,98% 2.521.700
30/09/2022 228,42 230,00 225,17 225,40 -1,32% 2,11% 2.543.400
29/09/2022 231,55 231,55 226,97 228,41 -1,11% 1,98% 2.335.700
28/09/2022 229,96 231,87 227,74 230,98 +2,21% 1,80% 2.782.400
27/09/2022 226,97 229,96 225,02 225,99 -0,39% 2,18% 2.009.800
26/09/2022 226,77 228,64 225,38 226,87 -0,04% 1,44% 2.454.000
23/09/2022 227,99 228,61 224,56 226,97 -0,34% 1,78% 2.148.600
22/09/2022 223,55 229,37 223,30 227,75 +1,47% 2,72% 2.081.200
21/09/2022 229,13 230,62 224,36 224,46 -1,43% 2,73% 2.186.300
20/09/2022 228,50 229,99 226,53 227,71 -1,32% 1,51% 1.745.900
19/09/2022 230,64 230,86 227,10 230,76 -0,16% 1,63% 1.981.400
16/09/2022 226,89 232,22 226,61 231,14 +1,53% 2,47% 4.604.100
15/09/2022 228,10 229,01 225,86 227,66 -0,20% 1,38% 2.206.100
14/09/2022 227,53 228,78 226,13 228,12 +0,56% 1,16% 2.715.600
13/09/2022 237,03 237,14 226,62 226,86 -4,53% 4,44% 4.447.200
12/09/2022 238,00 241,70 235,11 237,62 -4,07% 2,77% 6.294.600
09/09/2022 245,45 249,23 245,03 247,69 +0,91% 1,71% 2.318.000
08/09/2022 244,80 246,00 242,91 245,45 +0,27% 1,26% 2.895.800
07/09/2022 242,80 245,32 242,27 244,79 +1,06% 1,26% 2.127.300
06/09/2022 243,74 244,59 241,54 242,22 -0,06% 1,25% 2.102.600
02/09/2022 246,48 247,78 241,34 242,37 -1,27% 2,61% 2.325.100
01/09/2022 241,12 245,74 240,74 245,50 +2,16% 2,07% 2.488.200
31/08/2022 241,59 243,89 239,85 240,30 +0,49% 1,67% 4.303.900
30/08/2022 239,88 240,31 238,29 239,12 -0,11% 0,84% 3.673.000
29/08/2022 238,84 241,03 238,01 239,38 -0,53% 1,26% 2.113.000